Medpace Holdings, Inc.
Symbol: MEDP
NASDAQ
392.57
USDMarktpreis heute
38.7448
P/E-Verhältnis
0.0000
PEG-Verhältnis
12.16B
MRK Kapital
- 0.00%
DIV Rendite
Medpace Holdings, Inc. (MEDP) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 1145.4 | 298.4 | 253.4 | 186.4 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 234.34 | 50 | 52.3 | 43.2 | ||||||||||
balance-sheet.row.total-current-assets | 2166.54 | 593.8 | 334 | 690.9 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 1036.38 | 265.4 | 248.9 | 222.7 | ||||||||||
balance-sheet.row.goodwill | 2649.58 | 662.4 | 662.4 | 662.4 | ||||||||||
balance-sheet.row.intangible-assets | 144.52 | 35.8 | 38 | 41.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2794.11 | 698.2 | 700.4 | 703.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | 260.77 | 74.4 | 48.1 | 25.1 | ||||||||||
balance-sheet.row.other-non-current-assets | 88.47 | 25 | 21.1 | 17.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 4179.74 | 1063 | 1018.5 | 969 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.account-payables | 118.9 | 31.9 | 33.1 | 25.7 | ||||||||||
balance-sheet.row.short-term-debt | 885.06 | 293 | 50 | 159.3 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 6.99 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 392.9 | 40.4 | 257.7 | 27.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 671.08 | 172.7 | 162.6 | 149.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
balance-sheet.row.total-liab | 4253.81 | 1097.9 | 966.1 | 707 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 1.23 | 0.3 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.retained-earnings | -1012 | -221.6 | -359.8 | 235 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -46.18 | -10.1 | -12.4 | -4.8 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 3149.41 | 790.4 | 758.3 | 722.4 | ||||||||||
balance-sheet.row.total-stockholders-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6346.28 | - | - | - | ||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 615.71 | 142.1 | 188.9 | 131 | ||||||||||
balance-sheet.row.net-debt | -171.1 | -103.3 | 160.6 | -330.3 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 | ||||||||||
cash-flows.row.depreciation-and-amortization | 27.36 | 26.3 | 22.3 | 21.1 | ||||||||||
cash-flows.row.deferred-income-tax | -24.92 | -25.1 | -23 | -37.1 | ||||||||||
cash-flows.row.stock-based-compensation | 19.39 | 20.5 | 21.4 | 14.5 | ||||||||||
cash-flows.row.change-in-working-capital | 151.12 | 106.5 | 106.1 | 66.7 | ||||||||||
cash-flows.row.account-receivables | -24.82 | -48.3 | -66.9 | -25 | ||||||||||
cash-flows.row.inventory | 43.94 | 66.2 | 0 | 25 | ||||||||||
cash-flows.row.account-payables | -10.76 | 1.1 | 6.4 | 1.9 | ||||||||||
cash-flows.row.other-working-capital | 179.05 | 87.5 | 166.5 | 64.8 | ||||||||||
cash-flows.row.other-non-cash-items | 20.52 | 22.4 | 15.9 | 16.3 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 505.98 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 10.04 | 2 | -1.9 | -3.1 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.6 | -34.6 | -38.7 | -31.4 | ||||||||||
cash-flows.row.debt-repayment | -130 | -155 | -274.2 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 16.57 | 11.4 | 22.1 | 17.6 | ||||||||||
cash-flows.row.common-stock-repurchased | -23.87 | -144 | -847.8 | -62.1 | ||||||||||
cash-flows.row.dividends-paid | 0 | -11.4 | -22.1 | 0 | ||||||||||
cash-flows.row.other-financing-activites | -23.43 | 116.4 | 346.3 | -44.5 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.3 | -182.6 | -775.8 | -44.5 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.99 | 1.1 | -6.6 | -4 | ||||||||||
cash-flows.row.net-change-in-cash | 360.09 | 217.2 | -433 | 183.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 426.72 | 28.3 | 461.3 | 277.8 | ||||||||||
cash-flows.row.operating-cash-flow | 505.98 | 433.4 | 388.1 | 263.3 | ||||||||||
cash-flows.row.capital-expenditure | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.free-cash-flow | 473.34 | 396.7 | 351.2 | 235.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1962.81 | 1885.8 | 1460 | 1142.4 | ||||||||||
income-statement-row.row.cost-of-revenue | 1413.35 | 1361.3 | 1027.6 | 814.2 | ||||||||||
income-statement-row.row.gross-profit | 549.46 | 524.5 | 432.4 | 328.2 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 41.01 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.operating-expenses | 194.77 | 187.7 | 153.7 | 129.5 | ||||||||||
income-statement-row.row.cost-and-expenses | 1608.12 | 1549 | 1181.3 | 943.8 | ||||||||||
income-statement-row.row.interest-income | 3.31 | 0 | 2.9 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 26.08 | 26.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.ebitda-caps | 381.37 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 354.69 | 336.8 | 278.7 | 198.6 | ||||||||||
income-statement-row.row.income-before-tax | 362.43 | 335.7 | 282.9 | 201.9 | ||||||||||
income-statement-row.row.income-tax-expense | 49.93 | 52.9 | 37.5 | 20 | ||||||||||
income-statement-row.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 |
Häufig gestellte Frage
Wie hoch ist die Medpace Holdings, Inc. (MEDP) Gesamtvermögen?
Medpace Holdings, Inc. (MEDP) Gesamtvermögen ist 1656828000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 1009445000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.280.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 15.347.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.159.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.181.
Was ist der Medpace Holdings, Inc. (MEDP) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 282810000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 142122000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 187680000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 407010000.000.